TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -21.44%4.57B | -10.33%11.57B | 8.87%5.82B | -2.47%12.9B | -28.77%5.34B | -30.09%13.23B | -18.17%7.5B | 70.80%18.92B | 108.24%9.17B | 54.55%11.08B |
Operating income | -21.44%4.57B | -10.33%11.57B | 8.87%5.82B | -2.47%12.9B | -28.77%5.34B | -30.09%13.23B | -18.17%7.5B | 70.80%18.92B | 108.24%9.17B | 54.55%11.08B |
Cost of sales | 11.27%-4.63B | 24.28%-10.34B | 12.07%-5.22B | -18.66%-13.66B | 19.61%-5.93B | 38.87%-11.51B | 17.44%-7.38B | -71.41%-18.83B | -96.15%-8.94B | -53.49%-10.99B |
Operating expenses | 11.27%-4.63B | 24.28%-10.34B | 12.07%-5.22B | -18.66%-13.66B | 19.61%-5.93B | 38.87%-11.51B | 17.44%-7.38B | -71.41%-18.83B | -96.15%-8.94B | -53.49%-10.99B |
Gross profit | -109.41%-56.75M | 261.12%1.22B | 202.86%603.17M | -144.30%-760.06M | -567.96%-586.39M | 1,789.08%1.72B | -46.13%125.31M | -2.14%90.81M | 252.25%232.63M | 736.77%92.8M |
Selling expenses | 18.00%-183.85M | 4.47%-435.42M | -6.21%-224.21M | -13.82%-455.81M | -16.77%-211.11M | -0.30%-400.47M | 26.05%-180.78M | -15.84%-399.29M | -54.02%-244.47M | -21.69%-344.7M |
Administrative expenses | -6.26%-196.5M | -104.17%-425.29M | -22.10%-184.93M | 43.83%-208.31M | -7.28%-151.46M | 30.58%-370.87M | -16.80%-141.18M | -100.89%-534.25M | 0.07%-120.88M | -15.16%-265.95M |
Special items of operating profit | 417.18%797.03M | -119.69%-409.12M | -138.92%-251.29M | 352.75%2.08B | 758.38%645.71M | -116.66%-822.2M | -104.30%-98.08M | 2,899.26%4.94B | 931.92%2.28B | 72.98%164.59M |
Operating profit | 728.68%359.93M | -106.91%-45.22M | 81.12%-57.25M | 435.98%653.96M | -2.89%-303.25M | -97.02%122.01M | -113.73%-294.74M | 1,258.90%4.09B | 1,114.13%2.15B | 13.41%-353.25M |
Financing cost | 14.80%-60.53M | 25.23%-132.24M | 8.50%-71.04M | -43.36%-176.86M | -48.38%-77.64M | 21.06%-123.37M | 59.41%-52.33M | 3.73%-156.27M | -52.89%-128.9M | -30.73%-162.33M |
Share of profit from joint venture company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 163.60%360K |
Special items of earning before tax | 86.59%-48.19M | ---- | ---359.3M | ---- | ---- | ---- | ---- | ---- | ---- | 2,076.72%2.05B |
Earning before tax | 151.52%251.21M | -137.19%-177.45M | -28.01%-487.59M | 35,284.37%477.1M | -9.75%-380.89M | -100.03%-1.36M | -117.20%-347.06M | 157.11%3.94B | 1,983.64%2.02B | 340.72%1.53B |
Tax | -181.27%-1.92M | 105.36%6.44M | 102.68%2.36M | 75.09%-120.17M | 4.38%-88.06M | -654.15%-482.45M | -356.16%-92.09M | 1,039.56%87.06M | 1,111.82%35.95M | 11.13%-9.27M |
After-tax profit from continuing operations | 151.38%249.3M | -147.91%-171.01M | -3.47%-485.23M | 173.78%356.93M | -6.79%-468.95M | -112.02%-483.8M | -121.39%-439.15M | 164.39%4.02B | 2,101.57%2.05B | 335.40%1.52B |
Earning after tax | 151.38%249.3M | -147.91%-171.01M | -3.47%-485.23M | 173.78%356.93M | -6.79%-468.95M | -112.02%-483.8M | -121.39%-439.15M | 164.39%4.02B | 2,101.57%2.05B | 335.40%1.52B |
Minority profit | 86.21%-2.15M | -13,689.23%-35.33M | -125.30%-15.59M | 101.08%260K | 48.98%-6.92M | -181.68%-24.1M | -739.05%-13.56M | 157.30%29.51M | 96.70%-1.62M | -171.33%-51.5M |
Profit attributable to shareholders | 153.54%251.45M | -138.04%-135.68M | -1.65%-469.65M | 177.59%356.67M | -8.56%-462.03M | -111.51%-459.7M | -120.71%-425.59M | 153.86%4B | 1,344.49%2.05B | 350.73%1.57B |
Basic earnings per share | 149.95%0.0549 | -133.48%-0.0306 | 7.18%-0.1099 | 177.59%0.0914 | -8.52%-0.1184 | -111.51%-0.1178 | -120.72%-0.1091 | 153.88%1.0239 | 1,342.74%0.5266 | 350.65%0.4033 |
Diluted earnings per share | 350.65%0.4033 | |||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Tianshi Hong Kong Certified Public Accountants Limited | -- | Tianshi Hong Kong Certified Public Accountants Limited | -- | Tianshi Hong Kong Certified Public Accountants Limited | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.